REQUEST A DEMO
Total
USD $0.00
Search more companies

Beximco Pharmaceuticals Limited (Bangladesh)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Beximco Pharmaceuticals Limited Profile Updated: August 01, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English Download a sample report

Beximco Pharmaceuticals Ltd. operates as a manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh. It is the flagship company of Beximco Group. The company produces more than 500 products in different dosage forms covering broader therapeutic categories which include antibiotics, gastro-intestinals, respiratory, analgesics, cardiovascular, anti-diabetics, etc, among many others. It was founded in 1980 and is headquartered in Dhaka.

Legal Address
19 Dhanmondi R/A, Road No. 7
Dhaka; Dhaka; Postal Code: 1205

Contact Details: Purchase the Beximco Pharmaceuticals Limited report to view the information.

Website: http://www.beximcopharma.com

Basic Information
Total Employees:
Purchase the Beximco Pharmaceuticals Limited report to view the information.
Outstanding Shares:
Purchase the Beximco Pharmaceuticals Limited report to view the information.
Registered Capital:
Purchase the Beximco Pharmaceuticals Limited report to view the information.
Financial Auditors:
Purchase the Beximco Pharmaceuticals Limited report to view the information.
Ratings:
Purchase the Beximco Pharmaceuticals Limited report to view the information.
Incorporation Date:
1980
Key Executives
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Chairman of the Board
Purchase this report to view the information.
Vice Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
2.03%
Subsidiaries
Company Performance
Financial values in the chart are available after Beximco Pharmaceuticals Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BDT. Absolute financial data is included in the purchased report.
Net sales revenue
13.91%
Total operating revenue
17.34%
Operating profit (EBIT)
31.75%
EBITDA
30.21%
Net Profit (Loss) for the Period
39.72%
Total assets
2.21%
Total equity
12.6%
Operating Profit Margin (ROS)
3.49%
Net Profit Margin
3.14%
Return on Equity (ROE)
2%
Debt to Equity Ratio
-12.86%
Quick Ratio
0.16%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?